🔎 Trials Near Me

መነሻ › አልሰራቲቭ ኮላይቲስ › Texas

በTexas ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአልሰራቲቭ ኮላይቲስ የሚደረጉ 33 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Novel Research - Bellaire /ID# 280925, Bellaire
  • Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
  • Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
  • እና 10 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT03816345

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
  • GI Alliance - Lubbock ( Site 0288), Lubbock
  • Caprock Gastro Research ( Site 0293), Lubbock
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06651281

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research, Baytown
  • DHR Health Gastroenterology - Edinburg, Edinburg
  • Baylor College of Medicine, Houston
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06598943

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • The Clinical Trials Network CTNX LLC, El Paso
  • Amel Med LLC, Georgetown
  • Kelsey Research Foundation, Houston
  • እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • University of Texas - Southwestern Medical Center /ID# 271835, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

  • Southern Star Research Institute, San Antonio
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07296315

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-024, Garland
  • Site US-009, Georgetown
  • Site US-030, Houston
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07845487

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 013, Cedar Park
  • Site 005, Garland
  • Site 002, San Antonio
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07012395

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Cedar Park
  • Xencor Investigative Site, Denton
  • Xencor Investigative Site, Garland
  • እና 8 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06619990

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • The University of Texas at Austin, Austin
  • DFW Clinical Trials, Carrollton
  • Victorium Clinical Research, Houston
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Cook Childrens Medical Center, Fort Worth
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 3 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Local Institution - 0103, Fort Worth
  • Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Fort Worth, Fort Worth
  • GI Alliance - Garland, Garland
  • Integrity Advanced Therapeutics, Houston
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07415044

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Cook Children's Medical Center, Fort Worth
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 19 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04844606

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • One of a Kind Clinical Research Center - Kingwood, Kingwood
  • Southern Star Research Institute, San Antonio
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07483073

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Texas Digestive Disease Consultants - Cedar Park, Cedar Park
  • GI Alliance - Dallas - Gaston Avenue, Dallas
  • GI Alliance - Fort Worth, Fort Worth
  • እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • GI Alliance - Digestive Health Associates of Texas, Dallas
  • The University of Texas Health Science Center at Houston, Houston
  • GI Alliance - Mansfield, Mansfield
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Lubbock - Site Number: 8400092, Lubbock
  • Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
  • Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07185009

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

  • BAMC, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT04372108

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern Star Research Institute, LLC, San Antonio
  • Tyler Research Institute, LLC, Tyler
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Texas Digestive Disease Consultants, Cedar Park
  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Inquest Clinical Research - Site Number: 8400144, Baytown
  • The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
  • Valley Institute of Research - Site Number: 8400004, Harlingen
  • እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • University of Texas Southwestern, Dallas
  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Amarillo Premier Research (Objective Health), Amarillo
  • Digestive Research of Central Texas (Objective Health), Waco
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06571669

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Houston Endoscopy & Research Center, Houston
  • BI Research Center, Houston
  • Brooke Army Medical center, San Antonio
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 64 · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • ACT-Midwest G1, Abilene
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT05287126

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Tyler Research Institute, LLC, Tyler
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06764615

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  • M D Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2026 · NCT04751396

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Texas Children's Hospital - Baylor - PIN, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 2 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ሜይ 2026 · NCT05442567

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Dallas
  • Mirador Therapeutics Selected Site, Garland
  • Mirador Therapeutics Selected Site, Georgetown
  • እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT07113522

Registry and Biorepository for IBD in Central Texas

  • Dell Medical School, UT Austin, Austin
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2021 · NCT04617184

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።